Molecular pathways shaping bone function following SGLT2 inhibitor therapy; a narrative insight from metabolic and endocrine crosstalk

Journal of Parathyroid Disease · Published 2026-03-28 · DOI 10.34172/jpd.2026.13322

Authors being retrieved — see the publisher record. https://doi.org/10.34172/jpd.2026.13322

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Sonidegib induced rhabdomyolysis in kidney transplant patient: a case report · Journal of Parathyroid Disease · 2023 · Same journal
Relationship of calcium-sensing receptor gene polymorphism CASR rs 1042636, CASR rs 1802757, and cinacalcet response among Egyptian hemodialysis patients with secondary hyperparathyroidism · Journal of Parathyroid Disease · 2024 · Same journal
Brown tumor in hyperparathyroidism; a new look at an old problem · Journal of Parathyroid Disease · 2023 · Same journal
Impact of parathyroid hormone on osteoporosis; a short look at the current knowledge · Journal of Parathyroid Disease · 2023 · Same journal
Parathyroid crisis; a short look at an uncommon disease · Journal of Parathyroid Disease · 2024 · Same journal
Association of serum vitamin D levels with diabetes mellitus and obesity; a prospective case-control study · Journal of Parathyroid Disease · 2025 · Same journal
Parathyroid hormone level predicts mortality in hemodialysis; an old problem remains still · Journal of Parathyroid Disease · 2024 · Same journal
An overview on acute kidney injury following COVID-19 · Journal of Parathyroid Disease · 2023 · Same journal
Evaluating the effects of uric acid level reduction on serum vitamin D level in hemodialysis patients · Journal of Parathyroid Disease · 2023 · Same journal
Administration of cinacalcet in pediatric patients with CKD; a short-review on recent concepts · Journal of Parathyroid Disease · 2025 · Same journal